Share

April 2017; 7 (2) Review

Depression in epilepsy, migraine, and multiple sclerosis

Epidemiology and how to screen for it

Nathalie Jetté, Farnaz Amoozegar, Scott B. Patten
First published March 24, 2017, DOI: https://doi.org/10.1212/CPJ.0000000000000349
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
280

Share

Article Information

vol. 7 no. 2 118-127
DOI: 
https://doi.org/10.1212/CPJ.0000000000000349
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
2163-0402
Online ISSN: 
2163-0933
History: 
  • Received November 30, 2016
  • Accepted February 7, 2017
  • First Published March 24, 2017.

Article Versions

Copyright & Usage: 
© 2017 American Academy of Neurology

Author Disclosures

    1. Nathalie Jetté, MD, MSc,
    2. Farnaz Amoozegar, MD, MSc and
    3. Scott B. Patten, MD, PhD
  1. Nathalie Jetté, MD, MSc,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Epilepsia, Associate Editor, 2013 to present; Neurology Editorial Board since 2015.

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. (1) I was a co-investigator on an operating grant from the University of Calgary Hotchkiss Brain Institute, co- funded by Pfizer Canada for work not related to this paper.

    Research Support, Government Entities:

    1. Role for all of these is principal investigator or co- principal investigator (and these grants are not related to the current study): Canada Research Chair Tier 2 in Neuroscience Health Services Research, salary support (2010-present); Canadian Institutes for Health Research (2007 to present).

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Alberta Spine Foundation (2015-2016), Alberta Health, Hotchkiss Brain Institute (operating funds 2015-present); Cumming School of Medicine at the University of Calgary (operating funds 2016-present).

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Farnaz Amoozegar, MD, MSc and
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. 1) Allergan - speaker's honoraria 2) Tribute pharmaceuticals - speaker's honoraria 3) Teva - conference travel and accommodations 4) EMD Serono - speaker's honoraria 5) Aralez - speaker's honoraria

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. 1) Eli Lilly - sponsorship of clinical trials - no direct funds to me 2) Teva - sponsorship of clinical trials - no direct funds to me 3) Amgen - sponsorship of clinical trials - no direct funds to me 4) Allergan

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. 1) University of Calgary Clinical Research Fund for registry research 2) University of Calgary Clinical Research Fund for observational study

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Scott B. Patten, MD, PhD
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. (1) Canadian Journal of Psychiatry, Editor-in-Chief, 2014-present. (2) Chronic Diseases in Canada, Editorial Advisory Board Member, 2009-present. (3) Clinical Practice and Epidemiology in Mental Health, Editorial Advisory Board Member, 2010-present. (4) Sr. Assoc. Editor, Epidemiology & Psychiatric Sciences

    Patents:

    1. NONE

    Publishing Royalties:

    1. Epidemiology for Canadian Students. Brush Education, 2015.

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. (1) Canadian Institutes for Health Research, MOP-89816, P.I. 2008-2011 and MOP-130415, P.I. 2013-2015. (2) Hotchkiss Brain Institute. Depression in the Community, 2013-2016. (3) Hotchkiss Brain Institute/Pfizer Research Competition. Building a Foundation for a Depression eHub for Neurological Patients, 2015 - 2016.

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. Department of Clinical Neurosciences (NJ, FA), Hotchkiss Brain Institute (NJ, FA, SBP), Department of Psychiatry (SBP), Mathison Health Centre (SBP), Department of Community Health Sciences (NJ, FA, SBP), and O'Brien Institute for Public Health (NJ, FA, SBP), Cumming School of Medicine, University of Calgary, Canada.
  1. Correspondence to:
    nathalie.jette{at}albertahealthservices.ca
View Full Text

Article usage

Article usage: March 2017 to May 2023

AbstractFullPdfSource
Mar 20177205Highwire
Apr 201710381944Highwire
May 201782013678Highwire
Jun 20174831524Highwire
Jul 201742203Highwire
Aug 201734225Highwire
Sep 20179513Highwire
Oct 20176500Highwire
Nov 20178404Highwire
Dec 201711652Highwire
Jan 20186839Highwire
Feb 20185251Highwire
Mar 20187842Highwire
Apr 20186510Highwire
Apr 201892021pmc
May 20186961Highwire
Jun 20189001Highwire
Jun 201861717pmc
Jul 20185000Highwire
Aug 20184700Highwire
Aug 201851718pmc
Sep 20183931Highwire
Oct 20185210Highwire
Nov 20185200Highwire
Dec 20187410Highwire
Jan 20192411Highwire
Feb 20195000Highwire
Mar 20194410Highwire
Apr 20194210Highwire
May 20194403Highwire
Jun 20192001Highwire
Jul 20191700Highwire
Aug 20191400Highwire
Sep 20192810Highwire
Oct 20192943Highwire
Nov 20192301Highwire
Dec 20192000Highwire
Jan 20202503Highwire
Feb 20203211Highwire
Mar 20202311Highwire
Apr 20203513Highwire
May 20209100Highwire
Jun 20202800Highwire
Jul 20201510Highwire
Aug 20202331Highwire
Sep 20203800Highwire
Oct 20202511Highwire
Nov 20204410Highwire
Dec 20202900Highwire
Jan 20213400Highwire
Feb 20212153Highwire
Mar 20213621Highwire
Apr 20215122Highwire
May 20212521Highwire
Jun 20212511Highwire
Jul 20213410Highwire
Aug 20213511Highwire
Sep 20213700Highwire
Oct 20213900Highwire
Nov 20214300Highwire
Dec 202112100Highwire
Jan 20222900Highwire
Feb 20223101Highwire
Mar 20223123Highwire
Apr 20221610Highwire
May 20222412Highwire
Jun 20222132Highwire
Jul 20222401Highwire
Aug 20221800Highwire
Sep 20223600Highwire
Oct 20222522Highwire
Nov 20225200Highwire
Dec 20223700Highwire
Jan 20233700Highwire
Feb 20232100Highwire
Mar 20232222Highwire
Apr 20232400Highwire
May 20231910Highwire

The Nerve!: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

Topics Discussed

Alert Me

Recommended articles